Pulikkan JA and his colleagues reported that miR-34a was downregulated and E2F3 was elevated in AML samples with CEBPA mutations and C/EBPα-regulated miRNA-34a targeted E2F3 during granulopoiesis in AML [24]. Here, E2F3 is linked to acute myeloid leukemia.